In glioblastoma, we identified an RND1low signature of six genes (ITGA5, COL3A1, COL5A1, MET, COL1A2, LAMC1), upregulated in glioblastoma patients with low RND1, that predicts the overall survival of glioblastoma patients. This evidence concerns the gene MET and glioblastoma.